|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
GB8719963D0
(en)
|
1987-08-24 |
1987-09-30 |
Cattaneo A |
Recombinant dna products
|
|
US5831034A
(en)
|
1987-11-13 |
1998-11-03 |
Hermann Katinger |
Human monoclonal anti-HIV-I-antibodies
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
WO1993023550A2
(en)
|
1992-05-18 |
1993-11-25 |
Genentech, Inc. |
Activation of oligomerizing receptors by using fused receptor ligands
|
|
US6476198B1
(en)
|
1993-07-13 |
2002-11-05 |
The Scripps Research Institute |
Multispecific and multivalent antigen-binding polypeptide molecules
|
|
UA40577C2
(uk)
|
1993-08-02 |
2001-08-15 |
Мерк Патент Гмбх |
Біспецифічна молекула, що використовується для лізису пухлинних клітин, спосіб її одержання, моноклональне антитіло (варіанти), фармацевтичний препарат, фармацевтичний набір (варіанти), спосіб видалення пухлинних клітин
|
|
AU697387C
(en)
|
1994-09-16 |
2006-03-02 |
Austin Research Institute Cancer and Anti-inflammatory Syndicate No 1 |
Polypeptides with Fc binding ability
|
|
US5874540A
(en)
|
1994-10-05 |
1999-02-23 |
Immunomedics, Inc. |
CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
|
|
IL111196A0
(en)
|
1994-10-07 |
1994-12-29 |
Yeda Res & Dev |
Peptides and pharmaceutical compositions comprising them
|
|
US6808709B1
(en)
*
|
1994-12-30 |
2004-10-26 |
The Regents Of The University Of California |
Immunoglobulins containing protection proteins and their use
|
|
US6165463A
(en)
*
|
1997-10-16 |
2000-12-26 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
|
AU2308595A
(en)
|
1995-04-19 |
1996-11-07 |
Polymun Scientific Immunobiologische Forschung Gmbh |
Monoclonal antibodies against hiv-1 and vaccines made thereo f
|
|
US20050003431A1
(en)
|
1996-08-16 |
2005-01-06 |
Wucherpfennig Kai W. |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
|
US8212004B2
(en)
|
1999-03-02 |
2012-07-03 |
Human Genome Sciences, Inc. |
Neutrokine-alpha fusion proteins
|
|
US6045774A
(en)
*
|
1997-01-10 |
2000-04-04 |
Epicyte Pharmaceutical Inc. |
J chain polypeptide targeting molecule linked to an imaging agent
|
|
EP1015493A1
(en)
*
|
1997-01-10 |
2000-07-05 |
EPIcyte Pharmaceutical, Inc. |
Novel epithelial tissue targeting agent
|
|
US20040009166A1
(en)
|
1997-04-30 |
2004-01-15 |
Filpula David R. |
Single chain antigen-binding polypeptides for polymer conjugation
|
|
US6284536B1
(en)
|
1998-04-20 |
2001-09-04 |
The Regents Of The University Of California |
Modified immunoglobin molecules and methods for use thereof
|
|
SI1642972T1
(sl)
|
1999-01-07 |
2010-05-31 |
Zymogenetics Inc |
Terapevtske uporabe BR X topnih receptorjev
|
|
EP1169352A4
(en)
|
1999-04-14 |
2005-05-04 |
Smithkline Beecham Corp |
ANTIBODY AGAINST THE ERYTHROPOIETIN RECEPTOR
|
|
US7312318B2
(en)
|
2002-03-01 |
2007-12-25 |
Immunomedics, Inc. |
Internalizing anti-CD74 antibodies and methods of use
|
|
DE60042785D1
(de)
|
1999-06-09 |
2009-10-01 |
Immunomedics Inc |
Immuntherapie von autoimmunerkrankungen durch die verwendung von b-zell spezifischen antikörpern
|
|
WO2001012820A1
(en)
|
1999-08-17 |
2001-02-22 |
Health Research Institute |
Genetic system and self-cleaving inteins derived therefrom, bioseparations and protein purification employing same, and methods for determining critical, generalizable amino acid residues for varying intein activity
|
|
EP1212422B1
(en)
*
|
1999-08-24 |
2007-02-21 |
Medarex, Inc. |
Human ctla-4 antibodies and their uses
|
|
US20050287153A1
(en)
|
2002-06-28 |
2005-12-29 |
Genentech, Inc. |
Serum albumin binding peptides for tumor targeting
|
|
JP2003531588A
(ja)
|
2000-04-11 |
2003-10-28 |
ジェネンテック・インコーポレーテッド |
多価抗体とその用途
|
|
CA2407426A1
(en)
|
2000-04-28 |
2001-11-08 |
Planet Biotechnology, Inc. |
Immunoadhesin for the prevention of rhinovirus infection
|
|
US20020168367A1
(en)
|
2000-04-28 |
2002-11-14 |
Planet Biotechnology Incorporated |
Novel immunoadhesins for treating and preventing viral and bacterial diseases
|
|
MXPA02011092A
(es)
*
|
2000-05-10 |
2004-08-19 |
David A Sirbasku |
Composiciones y metodos para demostrar la regulacion del sistema inmune secretor del crecimiento de la celula de cancer que responde a la hormona esteroidea.
|
|
IL153853A0
(en)
|
2000-07-10 |
2003-07-31 |
Novartis Ag |
Bifunctional molecules and vectors complexed therewith for targeted gene delivery
|
|
EP1319025A2
(en)
|
2000-09-07 |
2003-06-18 |
John R. Schreiber |
Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US7138496B2
(en)
|
2002-02-08 |
2006-11-21 |
Genetastix Corporation |
Human monoclonal antibodies against human CXCR4
|
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
RU2003129528A
(ru)
|
2001-03-07 |
2005-04-10 |
Мерк Патент ГмбХ (DE) |
Способ экспрессии белков, содержащих в качестве компонента гибридный изотип антитела
|
|
US7402312B2
(en)
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
|
US20050129616A1
(en)
*
|
2001-05-25 |
2005-06-16 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
NZ513418A
(en)
|
2001-08-07 |
2004-04-30 |
Univ Massey |
Vaccine comprising proteins from mycobacterium paratuberculosis
|
|
JP5355839B2
(ja)
|
2001-10-23 |
2013-11-27 |
ピーエスエムエー デベロプメント カンパニー， エル．エル．シー． |
Ｐｓｍａ抗体およびタンパク質マルチマー
|
|
WO2003068821A2
(en)
|
2002-02-14 |
2003-08-21 |
Immunomedics, Inc. |
Anti-cd20 antibodies and fusion proteins thereof and methods of use
|
|
CA2478047C
(en)
|
2002-03-01 |
2014-01-21 |
Immunomedics, Inc. |
Rs7 antibodies
|
|
NZ536420A
(en)
*
|
2002-04-12 |
2008-04-30 |
Medarex Inc |
Methods of treatment using CTLA-4 antibodies
|
|
ES2524767T3
(es)
|
2002-06-14 |
2014-12-12 |
Immunomedics, Inc. |
Anticuerpo monoclonal humanizado HPAM4
|
|
US7601351B1
(en)
*
|
2002-06-26 |
2009-10-13 |
Human Genome Sciences, Inc. |
Antibodies against protective antigen
|
|
DK2314629T4
(da)
|
2002-07-18 |
2023-02-06 |
Merus Nv |
Rekombinant produktion af blandinger af antistoffer
|
|
JP5138867B2
(ja)
|
2002-08-01 |
2013-02-06 |
イミューノメディクス、インコーポレイテッド |
α−フェトタンパク質Ｉｍｍｕ３１抗体および融合タンパク質ならびにその使用方法
|
|
WO2004028339A2
(en)
|
2002-09-27 |
2004-04-08 |
Brigham And Women's Hospital, Inc. |
Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues
|
|
US7541440B2
(en)
|
2002-09-30 |
2009-06-02 |
Immunomedics, Inc. |
Chimeric, human and humanized anti-granulocyte antibodies and methods of use
|
|
US20050014932A1
(en)
|
2003-05-15 |
2005-01-20 |
Iogenetics, Llc |
Targeted biocides
|
|
AR044388A1
(es)
|
2003-05-20 |
2005-09-07 |
Applied Molecular Evolution |
Moleculas de union a cd20
|
|
AU2004240782B2
(en)
|
2003-05-23 |
2011-04-21 |
Crucell Holland B.V. |
Production of recombinant IGM in per.C6 cells
|
|
DE602004030451D1
(de)
|
2003-07-15 |
2011-01-20 |
Chugai Pharmaceutical Co Ltd |
Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm-produktion
|
|
CA2534639C
(en)
|
2003-07-31 |
2013-07-30 |
Immunomedics, Inc. |
Anti-cd19 antibodies
|
|
US8147832B2
(en)
|
2003-08-14 |
2012-04-03 |
Merck Patent Gmbh |
CD20-binding polypeptide compositions and methods
|
|
EP1686137A4
(en)
|
2003-10-09 |
2009-10-28 |
Chugai Pharmaceutical Co Ltd |
Method of stabilizing protein solutions
|
|
MXPA06004035A
(es)
*
|
2003-10-16 |
2006-08-31 |
Micromet Ag |
Aglutinantes cd3 de-inmunizados multi-especificos.
|
|
FR2861255B1
(fr)
|
2003-10-24 |
2006-02-17 |
Centre Nat Rech Scient |
Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe a et ses applications.
|
|
EP1706425A2
(en)
|
2003-12-05 |
2006-10-04 |
John R. Schreiber |
Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse®
|
|
EP1697520A2
(en)
|
2003-12-22 |
2006-09-06 |
Xencor, Inc. |
Fc polypeptides with novel fc ligand binding sites
|
|
US7850962B2
(en)
|
2004-04-20 |
2010-12-14 |
Genmab A/S |
Human monoclonal antibodies against CD20
|
|
DK1814913T3
(en)
|
2004-11-05 |
2015-09-28 |
Univ Leland Stanford Junior |
ANTIBODY-INDUCED CELL membrane damage.
|
|
US7251164B2
(en)
|
2004-11-10 |
2007-07-31 |
Innovative Silicon S.A. |
Circuitry for and method of improving statistical distribution of integrated circuits
|
|
EP1833848A2
(en)
|
2004-12-09 |
2007-09-19 |
Lajolla Institute for Allergy and Immunology |
Novel tnf receptor regulatory domain
|
|
ES2665422T3
(es)
|
2005-03-03 |
2018-04-25 |
Immunomedics Inc. |
Anticuerpos L243 humanizados
|
|
US8349332B2
(en)
|
2005-04-06 |
2013-01-08 |
Ibc Pharmaceuticals, Inc. |
Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
|
|
JP2008541758A
(ja)
|
2005-06-02 |
2008-11-27 |
アストラゼネカ エービー |
Ｃｄ２０に対する抗体およびその使用
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
TW200732350A
(en)
|
2005-10-21 |
2007-09-01 |
Amgen Inc |
Methods for generating monovalent IgG
|
|
RU2008129827A
(ru)
*
|
2005-12-21 |
2010-01-27 |
МЕДИММЬЮН, ЭлЭлСи (US) |
МОЛЕКУЛЫ EphA2-BiTE И ИХ ПРИМЕНЕНИЕ
|
|
WO2007134037A2
(en)
|
2006-05-15 |
2007-11-22 |
Immunomedics, Inc. |
Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
|
|
US8268635B2
(en)
|
2006-05-19 |
2012-09-18 |
Antonio Ferrante |
Methods of identifying agents that selectively activate p38 and/or NKkB signaling
|
|
NZ573646A
(en)
|
2006-06-12 |
2012-04-27 |
Wyeth Llc |
Single-chain multivalent binding proteins with effector function
|
|
JP2010502224A
(ja)
|
2006-09-08 |
2010-01-28 |
アボット・ラボラトリーズ |
インターロイキン１３結合タンパク質
|
|
US9382327B2
(en)
|
2006-10-10 |
2016-07-05 |
Vaccinex, Inc. |
Anti-CD20 antibodies and methods of use
|
|
KR20090105913A
(ko)
|
2006-11-02 |
2009-10-07 |
다니엘 제이 카폰 |
이동 부분을 갖는 하이브리드 면역글로불린
|
|
US20080145420A1
(en)
|
2006-12-13 |
2008-06-19 |
Simon Michael R |
HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
|
|
WO2008114011A2
(en)
|
2007-03-19 |
2008-09-25 |
Medimmune Limited |
Fc polypeptide variants obtained by ribosome display methodology
|
|
WO2008135963A2
(en)
|
2007-05-02 |
2008-11-13 |
Hemogem Inc. |
Fibrinogen for treatment of bleeding in trauma and platelet disorders
|
|
WO2009013620A2
(en)
|
2007-06-11 |
2009-01-29 |
Erasmus University Medical Center Rotterdam |
Homologous recombination
|
|
EP2195342A1
(en)
|
2007-09-07 |
2010-06-16 |
Ablynx N.V. |
Binding molecules with multiple binding sites, compositions comprising the same and uses thereof
|
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
CA2706700A1
(en)
|
2007-11-08 |
2009-05-14 |
Cytimmune Sciences, Inc. |
Compositions and methods for generating antibodies
|
|
EP2254592B1
(en)
|
2008-02-28 |
2019-06-05 |
Dako Denmark A/S |
Mhc multimers in borrelia diagnostics and disease
|
|
ITTO20080313A1
(it)
|
2008-04-22 |
2009-10-23 |
Marco Colombatti |
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi
|
|
BRPI0915512A2
(pt)
|
2008-07-11 |
2017-06-20 |
Sea Lane Biotechnologies Llc |
construtos e bibliotecas compreendendo sequências substitutas de cadeia leve kappa de anticorpo
|
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
CA2742969A1
(en)
|
2008-11-07 |
2010-05-14 |
Fabrus Llc |
Anti-dll4 antibodies and uses thereof
|
|
WO2011071957A1
(en)
|
2009-12-07 |
2011-06-16 |
Sea Lane Biotechnologies, Llc |
Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties
|
|
CA2785907A1
(en)
|
2009-12-29 |
2011-07-28 |
Emergent Product Development Seattle, Llc |
Ron binding constructs and methods of use thereof
|
|
KR20130009760A
(ko)
|
2010-02-10 |
2013-01-23 |
이뮤노젠 아이엔씨 |
Ｃｄ２０ 항체 및 이의 용도
|
|
KR20130036192A
(ko)
*
|
2010-02-11 |
2013-04-11 |
알렉시온 파마슈티칼스, 인코포레이티드 |
항-ｃｄ200 항체들을 이용한 치료 및 진단 방법
|
|
CA2815046C
(en)
|
2010-10-19 |
2019-05-14 |
Mayo Foundation For Medical Education And Research |
Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease
|
|
UY33826A
(es)
|
2010-12-22 |
2012-07-31 |
Abbott Lab |
Proteínas de unión con dominios trivariables y sus usos
|
|
RU2014121043A
(ru)
|
2011-10-24 |
2015-12-10 |
Эббви Инк. |
Биспецифические иммуносвязывающие средства, направленные против tnf и il-17
|
|
US9253965B2
(en)
|
2012-03-28 |
2016-02-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
GB201122047D0
(en)
|
2011-12-21 |
2012-02-01 |
Kymab Ltd |
Transgenic animals
|
|
EP2791170A1
(en)
|
2011-12-16 |
2014-10-22 |
Synthon Biopharmaceuticals B.V. |
Compounds and methods for treating inflammatory diseases
|
|
WO2013120012A2
(en)
|
2012-02-08 |
2013-08-15 |
Igm Biosciences Inc. |
Cdim binding proteins and uses thereof
|
|
JP6238958B2
(ja)
|
2012-04-05 |
2017-11-29 |
ゴットフリート・ヒムラー |
分泌型免疫グロブリン複合体
|
|
US20150175678A1
(en)
|
2012-06-15 |
2015-06-25 |
Beth Israel Deaconess Medical Center, Inc. |
IgA CD4i ANTIBODIES AND METHODS OF TREATMENT USING SAME
|
|
JP2015524821A
(ja)
|
2012-08-02 |
2015-08-27 |
ジェイエヌ バイオサイエンシーズ エルエルシー |
システイン変異及びμ尾部を介して多量体化した抗体又は融合タンパク質
|
|
JOP20200236A1
(ar)
|
2012-09-21 |
2017-06-16 |
Regeneron Pharma |
الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
|
|
US10066238B2
(en)
*
|
2013-02-11 |
2018-09-04 |
University Of Louisville Research Foundation, Inc. |
Methods for producing antibodies
|
|
US9487773B2
(en)
|
2013-03-01 |
2016-11-08 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa |
Cell-based methods for coupling protein interactions and binding molecule selection
|
|
EP2968587A2
(en)
|
2013-03-13 |
2016-01-20 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto
|
|
GB201311487D0
(en)
|
2013-06-27 |
2013-08-14 |
Alligator Bioscience Ab |
Bispecific molecules
|
|
US20150038682A1
(en)
|
2013-08-02 |
2015-02-05 |
Jn Biosciences Llc |
Antibodies or fusion proteins multimerized via homomultimerizing peptide
|
|
AU2014296887A1
(en)
|
2013-08-02 |
2016-01-28 |
Aduro Biotech Holdings, Europe B.V. |
Combining CD27 agonists and immune checkpoint inhibition for immune stimulation
|
|
CA2922830A1
(en)
|
2013-09-05 |
2015-04-16 |
Igm Biosciences, Inc. |
Constant chain modified bispecific, penta- and hexavalent ig-m antibodies
|
|
WO2015037000A1
(en)
|
2013-09-11 |
2015-03-19 |
Compugen Ltd |
Vstm5 polypeptides and uses thereof as a drug for treatment of cancer, infectious diseases and immune related diseases
|
|
US10519251B2
(en)
|
2013-12-30 |
2019-12-31 |
Epimab Biotherapeutics, Inc. |
Fabs-in-tandem immunoglobulin and uses thereof
|
|
US10167333B2
(en)
|
2014-01-16 |
2019-01-01 |
Mario Umberto Francesco Mondelli |
Neutralizing human monoclonal antibodies against hepatitis B virus surface antigen
|
|
EP3105250B1
(en)
|
2014-02-10 |
2020-08-05 |
IGM Biosciences, Inc. |
Iga multi-specific binding molecules
|
|
KR102442436B1
(ko)
*
|
2014-03-14 |
2022-09-15 |
노파르티스 아게 |
Lag-3에 대한 항체 분자 및 그의 용도
|
|
PL3560954T3
(pl)
|
2014-04-03 |
2021-12-13 |
Igm Biosciences, Inc. |
Zmodyfikowany łańcuch J
|
|
IL308212A
(en)
|
2015-01-20 |
2024-01-01 |
Igm Biosciences Inc |
Tumor necrosis factor-α receptor binding molecules and their uses
|
|
EP3957738A1
(en)
|
2015-03-04 |
2022-02-23 |
IGM Biosciences, Inc. |
Cd20 binding molecules and uses thereof
|
|
WO2016154593A1
(en)
|
2015-03-25 |
2016-09-29 |
Igm Biosciences, Inc. |
Multi-valent hepatitis b virus antigen binding molecules and uses thereof
|
|
CN107847591B
(zh)
|
2015-04-17 |
2023-07-28 |
Igm生物科学股份有限公司 |
多价人免疫缺陷病毒抗原结合分子及其应用
|
|
NZ739830A
(en)
|
2015-07-12 |
2021-12-24 |
Hangzhou Dac Biotech Co Ltd |
Bridge linkers for conjugation of cell-binding molecules
|
|
EP3355913B1
(en)
|
2015-09-30 |
2024-10-30 |
IGM Biosciences, Inc. |
Binding molecules with modified j-chain
|
|
EP3356401B1
(en)
|
2015-09-30 |
2020-06-24 |
IGM Biosciences, Inc. |
Binding molecules with modified j-chain
|
|
SG11201809336QA
(en)
|
2016-05-09 |
2018-11-29 |
Igm Biosciences Inc |
Anti-pd-l1 antibodies
|
|
AU2017299608A1
(en)
|
2016-07-20 |
2019-02-07 |
Igm Biosciences, Inc. |
Multimeric CD137/4-1BB binding molecules and uses thereof
|
|
EP3496536A4
(en)
|
2016-07-20 |
2020-02-12 |
IGM Biosciences, Inc. |
MULTIMERE CD40-BINDING MOLECULES AND USES THEREOF
|
|
JP2019530640A
(ja)
|
2016-07-20 |
2019-10-24 |
アイジーエム バイオサイエンシズ インコーポレイテッド |
多量体ｏｘ４０結合分子及びその使用
|
|
MX2019000799A
(es)
|
2016-07-20 |
2019-06-03 |
Igm Biosciences Inc |
Moleculas de union a gitr multimericas y usos de las mismas.
|
|
MX2019011986A
(es)
|
2017-04-07 |
2019-11-07 |
Igm Biosciences Inc |
Regiones constantes de igm humana modificadas para la modulacion de la funcion efectora de la citolisis dependiente de complemento referencia cruzada a solicitudes relacionadas.
|
|
EP3759229A4
(en)
|
2018-02-26 |
2021-12-29 |
IGM Biosciences Inc. |
Use of a multimeric anti-dr5 binding molecule in combination with a chemotherapeutic agent for treating cancer
|
|
MX2020009069A
(es)
|
2018-03-01 |
2020-10-08 |
Igm Biosciences Inc |
Mutaciones de fc de igm y de la cadena j que afectan la semivida de igm en suero.
|
|
US20210380701A1
(en)
|
2018-10-23 |
2021-12-09 |
Igm Biosciences, Inc. |
MULTIVALENT IgM- AND IgA-Fc-BASED BINDING MOLECULES
|
|
US20220106398A1
(en)
|
2019-02-08 |
2022-04-07 |
Igm Biosciences, Inc. |
Anti-gitr antigen-binding domains and uses thereof
|
|
JP2022544405A
(ja)
|
2019-08-15 |
2022-10-18 |
アイジーエム バイオサイエンシズ インコーポレイテッド |
免疫刺激性多量体型結合分子
|
|
KR20220045030A
(ko)
|
2019-08-17 |
2022-04-12 |
아이쥐엠 바이오사이언스 인코포레이티드 |
다량체성 이중특이적 항-cd123 결합 분자 및 이의 용도
|
|
US20220306760A1
(en)
|
2019-08-23 |
2022-09-29 |
Igm Biosciences, Inc. |
Igm glycovariants
|
|
AU2020351205A1
(en)
|
2019-09-19 |
2022-04-14 |
Igm Biosciences, Inc. |
Multimeric antibodies with enhanced selectivity for cells with high target density
|
|
BR112022013071A2
(pt)
|
2020-01-06 |
2022-09-20 |
Igm Biosciences Inc |
Moléculas de ligação multiméricas altamente sialiladas
|
|
EP4139362A2
(en)
|
2020-04-22 |
2023-03-01 |
IGM Biosciences Inc. |
Pd-1 agonist multimeric binding molecules
|
|
JP2023526224A
(ja)
|
2020-05-12 |
2023-06-21 |
アイジーエム バイオサイエンシズ インコーポレイテッド |
がんを治療するための、がん治療薬との組合せでの多量体抗ｄｒ５結合分子の使用
|
|
WO2022026475A2
(en)
|
2020-07-27 |
2022-02-03 |
Igm Biosciences, Inc. |
Multimeric coronavirus binding molecules and uses thereof
|
|
WO2022109023A1
(en)
|
2020-11-17 |
2022-05-27 |
Igm Biosciences, Inc. |
Uses of effector cell engaging molecules with moieties of differing potencies
|
|
US20240076392A1
(en)
|
2021-02-17 |
2024-03-07 |
Igm Biosciences, Inc. |
Anti-cd123 binding molecules and uses thereof
|
|
WO2022177870A1
(en)
|
2021-02-17 |
2022-08-25 |
The Board Of Regents Of The University Of Texas System |
Multimeric sars-cov-2 binding molecules and uses thereof
|